Guangxi Medical University
Clinical trials sponsored by Guangxi Medical University, explained in plain language.
-
New strategy aims to stop liver Cancer's return after surgery
Disease control Recruiting nowThis study is testing whether adding a procedure called TACE after liver cancer surgery helps prevent the cancer from coming back. It will involve 442 people who have had surgery for liver cancer and are at high risk of recurrence. Participants will be randomly assigned to either…
Phase: PHASE3 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Apr 02, 2026 03:56 UTC
-
Massive data dive aims to find best liver cancer treatment paths
Knowledge-focused Recruiting nowThis study is looking back at the medical records of 2000 people in China with liver cancer (hepatocellular carcinoma) who received treatments to try to shrink their tumors before possible surgery. The goal is to figure out which combinations of drugs and procedures work best for…
Sponsor: Guangxi Medical University • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:52 UTC